Literature DB >> 19194783

Comparison of the effects of new and conventional hormone replacement therapies on left ventricular diastolic function in healthy postmenopausal women: a Doppler and ultrasonic backscatter study.

Hamza Duygu1, Levent Akman, Filiz Ozerkan, Fuat Akercan, Mehdi Zoghi, Sanem Nalbantgil, Umit Erturk, Azem Akilli, Remzi Onder, Mustafa Akin.   

Abstract

We aimed to compare the effects of new treatment modalities to conventional hormone replacement therapy (HRT) on left ventricular (LV) diastolic function, by means of conventional and tissue Doppler echocardiography and the myocardial integrated backscatter (IBS) in postmenopausal women. One hundred and fifty healthy postmenopausal women were included in this study. Subjects were assigned to one of the five groups receiving 1 year of treatment (estrogen, estrogen plus progesterone, raloxifene, tibolone or placebo). E and A wave velocity, E/A ratio, isovolumic relaxation time (IVRT), deceleration time (DT), peak early (Em) diastolic mitral annular velocity, E/Em ratio, the cyclic variation of integrated backscatter (CVIBS) and the mean value of the IBS signal (MIBS) were determined before and 12 months after therapy. E (76 +/- 10 vs. 98 +/- 8 cm/s, P = 0.0001 and 78 +/- 10 vs. 90 +/- 12 cm/s, P = 0.02, respectively), Em (14.3 +/- 2.4 vs. 16.4 +/- 2.5 cm/s, P = 0.001 and 15.1 +/- 3.4 vs. 16.2 +/- 3.5 cm/s, P = 0.01, respectively), and E/A ratio (1.15 +/- 0.3 vs. 1.42 +/- 0.4, P = 0.0001 and 1.0 +/- 0.2 vs. 1.22 +/- 0.2, P = 0.01, respectively) were increased significantly compared to pretreatment in both estrogen and raloxifene groups while DT, A, E/Em, and IVRT were significantly decreased. A significant increase in CVIBS and decrease in MIBS were detected 12 months after estrogen and raloxifene administration while no significant changes were observed in other groups. Changes in the MIBS and CVIBS were found to be independently associated with the observed changes in the diastolic function indexes during therapy. Both estrogen and raloxifene regimens may improve LV diastolic functions in healthy postmenopausal women. This improvement may be a result of direct cardiac effects on LV myocardium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194783     DOI: 10.1007/s10554-009-9429-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  27 in total

1.  The extracellular matrix is an important source of ultrasound backscatter from myocardium.

Authors:  C S Hall; M J Scott; G M Lanza; J G Miller; S A Wickline
Journal:  J Acoust Soc Am       Date:  2000-01       Impact factor: 1.840

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

Review 3.  Diagnostic criteria for diastolic heart failure.

Authors:  R Frederick Yturralde; William H Gaasch
Journal:  Prog Cardiovasc Dis       Date:  2005 Mar-Apr       Impact factor: 8.194

4.  In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans.

Authors:  E Picano; G Pelosi; M Marzilli; F Lattanzi; A Benassi; L Landini; A L'Abbate
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

5.  Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause.

Authors:  K F Gangar; S Vyas; M Whitehead; D Crook; H Meire; S Campbell
Journal:  Lancet       Date:  1991-10-05       Impact factor: 79.321

6.  Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease.

Authors:  J E Pérez; J B McGill; J V Santiago; K B Schechtman; A D Waggoner; J G Miller; B E Sobel
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

8.  Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms.

Authors:  A H Chester; C Jiang; J A Borland; M H Yacoub; P Collins
Journal:  Coron Artery Dis       Date:  1995-05       Impact factor: 1.439

Review 9.  Heart failure with normal systolic function: a common disorder in older people.

Authors:  D D Tresch; M F McGough
Journal:  J Am Geriatr Soc       Date:  1995-09       Impact factor: 5.562

10.  Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit.

Authors:  V Gisclard; V M Miller; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

View more
  3 in total

Review 1.  Sex differences and related estrogenic effects in heart failure with preserved ejection fraction.

Authors:  Deng Shuaishuai; Lin Jingyi; Zhao Zhiqiang; Fan Guanwei
Journal:  Heart Fail Rev       Date:  2022-10-03       Impact factor: 4.654

2.  Cardiovascular magnetic resonance imaging assessment of diastolic dysfunction in a population without heart disease: a gender-based study.

Authors:  Bruno Graça; Maria João Ferreira; Paulo Donato; Miguel Castelo-Branco; Filipe Caseiro-Alves
Journal:  Eur Radiol       Date:  2013-08-03       Impact factor: 5.315

3.  Cardiac Adaptations to High-Intensity Aerobic Training in Premenopausal and Recent Postmenopausal Women: The Copenhagen Women Study.

Authors:  Jon Egelund; Peter G Jørgensen; Camilla M Mandrup; Thomas Fritz-Hansen; Bente Stallknecht; Jens Bangsbo; Michael Nyberg; Ylva Hellsten
Journal:  J Am Heart Assoc       Date:  2017-08-18       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.